Miragen Therapeutics Soared
Thu 28 May 20 at 05:30 PM
Miragen Therapeutics (MGEN:NASDAQ) shot up at $1.15, representing a gain of 35.3%. On Wed 27 May 20, MGEN:NASDAQ hit a New 2-Week High of $0.85. The stock got featured on our News Catalysts scanner on Wed 27 May 20 at 10:56 AM in the 'BIOTECH' category. From Wed 13 May 20, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Wed 04 Mar 20 at $1.04 with a volume of 5M+.
About Miragen Therapeutics (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 386.33%
- Hexindai Inc. (HX:NASDAQ), 170.83%
- HUSN (HUSN:NASDAQ), 72.29%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 36.43%
- International Tower Hill Mines Ltd. (THM:NYSEMKT), 36.35%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 36.2%
- Live Ventures Incorporated (LIVE:NASDAQ), 35.31%
- Miragen Therapeutics (MGEN:NASDAQ), 35.29%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 33.24%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 31.58%